AMPLI – PPHI Accelerating Measurable Progress and Leveraging Investments for Postpartum Hemorrhage Impact Did you know? Postpartum hemorrhage (PPH) is the leading cause of maternal death worldwide. AMPLI-PPHI will catalyze early adoption and scale-up of new and recently recommended drugs to prevent or treat PPH in high-burden countries as part of an integrated package of
August 16, 2022 Baltimore, MD—Jhpiego, a global leader in maternal health care, has been chosen to lead a new $18.5 million project funded by Unitaid that will inform how countries can introduce and accelerate use of key drugs to prevent and treat life-threatening bleeding after birth. The Accelerating Measurable Progress and Leveraging Investments for Postpartum
During the COVID-19 pandemic, many global health programs experienced delays and setbacks in collecting data; however, we know that data can only be used to inform programs if properly collected and analyzed in a timely manner. In three Jhpiego-supported countries implementing family planning programs—Indonesia, Guinea and Kenya—the creation of data dashboards enabled the teams to